Carrington Laboratories, Inc. (NASDAQ:CARN), a research-based, biopharmaceutical and consumer products company, will hold its quarterly conference call to discuss first quarter results on Thursday, May 15, 2008, at 4:30 p.m. Eastern Time (3:30 p.m. Central Time). First quarter unaudited financial results will be released earlier the same day.

Investors are invited to listen to the conference call by dialing 866-800-8651 in the US or 617-614-2704 internationally. The pass code is 82605206. The call is also being web cast by CCBN and can be accessed at Carrington’s web site at www.carringtonlabs.com.

The webcast is also being distributed through the Thomson StreetEvents Network to both institutional and individual investors. Individual investors can listen to the call at www.fulldisclosure.com, Thomson/CCBN’s individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson’s password-protected event management site, StreetEvents (www.streetevents.com).

About Carrington

Carrington Laboratories, Inc. is an ISO 9001-certified, research-based biopharmaceutical company currently utilizing naturally-occurring complex carbohydrates to:

  • manufacture and market products for mucositis, radiation dermatitis, wound and oral care;
  • manufacture and market the nutraceutical and cosmetic raw materials Manapol® and Hydrapolâ„¢; and,
  • market consumer products under various brands.

Carrington Laboratories, Inc.
Jessica Gurkoff, 972-518-1300
jgurkoff@carringtonlabs.com

Comments

comments